Drug Patents owned by Eyepoint Pharms

1. Drug name - DEXYCU KIT

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6960346 EYEPOINT PHARMS Vehicles for delivery of biologically active substances Jul, 2023

(9 months from now)

US10799642 EYEPOINT PHARMS Dose guides for injection syringe May, 2032

(9 years from now)

US10028965 EYEPOINT PHARMS Use of sustained release dexamethasone in post-cataract surgery inflammation May, 2034

(11 years from now)

US10159683 EYEPOINT PHARMS Use of sustained release dexamethasone in post-cataract surgery inflammation May, 2034

(11 years from now)

US10022502 EYEPOINT PHARMS Dose guides for injection syringe Jun, 2034

(11 years from now)

Drugs and Companies using DEXAMETHASONE ingredient

Treatment: Treatment of postoperative inflammation

Dosage: SUSPENSION;INTRAOCULAR

More Information on Dosage
Strength Dosage Availability
9% SUSPENSION;INTRAOCULAR Prescription

2. Drug name - YUTIQ

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8871241 EYEPOINT PHARMS Injectable sustained release delivery devices Aug, 2027

(4 years from now)

Drugs and Companies using FLUOCINOLONE ACETONIDE ingredient

Treatment: NA

Dosage: IMPLANT;INTRAVITREAL

More Information on Dosage
Strength Dosage Availability
0.18MG IMPLANT;INTRAVITREAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.